WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China's Innovation in Translational Medicine: ... (1/29/2026)

China's Labs Pull Ahead as Global Drugmakers I... (1/27/2026)

China's Early-Stage Drug Advantage Seen Persis... (1/27/2026)

China's Commercial Health Insurance Payouts fo... (1/23/2026)

China Emerges as Credible Challenger to US in ... (1/21/2026)

China Biopharma Innovation Takes Center Stage ... (1/17/2026)

China Biopharma Sees Record Financing and Lice... (1/13/2026)

China's 2025 Foreign Investment Catalogue Unlo... (1/13/2026)

China's Biopharma Sector Sets New Record for I... (1/12/2026)

China's Innovative Drug Licensing Deals Reach ... (1/12/2026)

Asia Emerges as the New Epicenter of Global Bi... (1/8/2026)

Chinese Drug Makers Hit Record US$136B in Glob... (1/8/2026)

Recent Official and Executive Moves (1/31/2026) China's Vaccine Exports Jump More Than 5... (1/31/2026) China's Basic Medical Insurance Fund Pos... (1/30/2026) China Solicits Comments on 103rd Batch o... (1/30/2026) China Releases New Guideline on CMC Chan... (1/30/2026) CDE Issues New Clinical Trial Guideline ... (1/30/2026) CDE Issues Trial Guideline to Standardiz... (1/30/2026) Roche's 2025 Results Highlight Strong Ch... (1/30/2026) CSPC's SYS6055 Becomes First In Vivo CAR... (1/30/2026) CMS Secures NMPA Approval for Opzelura i... (1/30/2026) Sciwind Receives China Approval for Ecno... (1/30/2026) SciBrunch Raises Over $35M in Oversubscr... (1/30/2026) Formation Bio Licenses Oral miR-124 Acti... (1/30/2026) AstraZeneca Expands Obesity Pipeline Thr... (1/30/2026) Phase III Trial Shows Anbenitamab Signif... (1/29/2026) Sciwind Reports Positive Phase III Resul... (1/29/2026) The United Labs Secures U.S. FDA IND Cle... (1/29/2026) Novartis Wins Expanded China Approval fo... (1/29/2026)

China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ... China's Pet Obesity Sparks Biotech Race for Weight-Loss... China's Human Vaccine Market Set for Steady Long-Term E...

AstraZeneca Expands Obesity Pipeline Through $18.5B CSP... Formation Bio Licenses Oral miR-124 Activator FHND5032 ... SciBrunch Raises Over $35M in Oversubscribed Pre-A Roun... Roche's 2025 Results Highlight Strong China Growth amid... AstraZeneca Deepens China Commitment With $15B Investme...

CDE Issues Trial Guideline to Standardize Clinical Deve... CDE Issues New Clinical Trial Guideline for Antifibroti... China Releases New Guideline on CMC Changes for Cell Th... China Solicits Comments on 103rd Batch of Reference For... NMPA Releases 101st Batch of Reference Formulations for...

China's Basic Medical Insurance Fund Posts Solid Surplu... China Releases 2025 Edition Clinical Guidance on the Us... NHSA Seeks Feedback on Draft Guidelines for Real-World... China Expands Cross-Province Use of Employee BMI Funds ... China Rolls Out Smart Medical Insurance Payments to Imp...

China Warns of Foreign Misuse of Research Ties to Acces... China's Supreme Court Upholds Semaglutide Patent, Stren... BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef...

Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S...

Sciwind Receives China Approval for Ecnoglutide Injecti... CMS Secures NMPA Approval for Opzelura in Non-Segmental... CSPC's SYS6055 Becomes First In Vivo CAR-T Therapy Appr... Novartis Wins Expanded China Approval for Leqvio The United Labs Secures U.S. FDA IND Clearance for Nove...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...